PGIM Jennison Health Sciences R6 (PHLQX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

53.33

-0.22 (-0.41%)

At close: Sep 4, 2026

Fund Assets	1.50B
Expense Ratio	0.80%
Min. Investment	$1,000
Turnover	81.00%
Dividend (ttm)	0.16
Dividend Yield	0.30%
Dividend Growth	-62.54%
Payout Frequency	Annual
Ex-Dividend Date	Dec 19, 2025

Previous Close	53.55
YTD Return	12.42%
1-Year Return	35.90%
5-Year Return	49.43%
52-Week Low	42.93
52-Week High	55.12
Beta (5Y)	0.93
Holdings	54
Inception Date	Jan 27, 2016

About PHLQX

The PGIM Jennison Health Sciences Fund Class R6 is an actively managed sector equity fund aimed at achieving long-term capital appreciation. It focuses on investments in companies within the health sciences sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. Designed primarily for institutional investors, this fund benefits from a lower expense ratio compared to other share classes. It actively seeks out companies with strong growth potential and innovative products or services, making it a strategic investment option for those looking to capitalize on the rapidly evolving healthcare industry. The fund's diversified portfolio includes a range of healthcare-related companies, positioning it as a key player in the financial market for health sector investments.

Fund Family PGIM

Category Health

Performance Rating High

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol PHLQX

Share Class Class R6

Index S&P Composite 1500 Health Care TR

Performance

PHLQX had a total return of 35.90% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.30%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHSZX	Class Z	0.88%
PHLAX	Class A	1.15%
PJHRX	Class R	1.48%
PHLCX	Class C	1.97%

Top 10 Holdings

59.46% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	17.18%
Prudential Govt Money Mkt Fd	n/a	10.19%
Merck & Co., Inc.	MRK	6.33%
UnitedHealth Group Incorporated	UNH	6.09%
Thermo Fisher Scientific Inc.	TMO	4.61%
Vertex Pharmaceuticals Incorporated	VRTX	3.42%
CVS Health Corporation	CVS	3.16%
Danaher Corporation	DHR	3.12%
argenx SE	ARGX	2.97%
Roivant Sciences Ltd.	ROIV	2.38%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 19, 2025	$5.16365	Dec 19, 2025
Dec 20, 2024	$5.44419	Dec 20, 2024
Dec 20, 2023	$1.91322	Dec 20, 2023
Dec 20, 2022	$0.61624	Dec 20, 2022
Dec 20, 2021	$14.02528	Dec 20, 2021
Dec 20, 2019	$1.43164	Dec 20, 2019

Full Dividend History